Payment; Reports. 11 3.12 Exchange Rate; Manner and Place of Payment............................ 11 3.13
Appears in 3 contracts
Sources: Research, Collaboration and License/Development Agreement (Tularik Inc), Research, Collaboration and License/Development Agreement (Tularik Inc), Research, Collaboration and License/Development Agreement (Tularik Inc)
Payment; Reports. 11 3.12 5 4.2 Exchange Rate; Manner and Place of Payment............................ 11 3.13.................................... 5 4.3
Appears in 3 contracts
Sources: Collaboration Agreement (Tularik Inc), Collaboration Agreement (Tularik Inc), Collaboration Agreement (Tularik Inc)
Payment; Reports. 11 3.12 26 7.2 Exchange Rate; Manner and Place of Payment............................ 11 3.13....................................................26 7.3
Appears in 1 contract
Sources: Collaborative Research Development and License Agreement (Acadia Pharmaceuticals Inc)
Payment; Reports. 11 3.12 17 7.2 Exchange Rate; Manner and Place of Payment............................ 11 3.13.................... 17 7.3
Appears in 1 contract
Sources: Technology Cross License Agreement (Ligand Pharmaceuticals Inc)
Payment; Reports. 11 3.12 26 8.2 Exchange Rate; Manner and Place of Payment............................ 11 3.13.....................................................26
Appears in 1 contract
Sources: Collaboration Agreement (Cubist Pharmaceuticals Inc)
Payment; Reports. 11 3.12 18 8.2 Exchange Rate; Manner and Place of Payment............................ 11 3.13..........................................18 8.3
Appears in 1 contract
Sources: Collaborative Research, Development and License Agreement (Acadia Pharmaceuticals Inc)